It's the best of two worlds: 5% rotating categories, plus fixed bonus categories like dining and some travel. This card is lucrative and ideal for optimizers who don't mind putting in some work to ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

LISBON, Jan 31 (Reuters) - U.S. private equity firm Lone Star has told the Portuguese government that it is likely to sell a 25-30% stake in Novo Banco via an initial public offering, rather than ...

Instead, you can get a lot for under $100. Right now, you can buy the Bella Pro 8-quart touchscreen air fryer for $70 instead of $110 at Best Buy. It’s ideal if you’re new to air frying and ...

The Chromebook Spin 311 not only has great battery life and a solid build quality, it also features plenty of ports for its size, great portability, and a fantastic touch display. Its keyboard and ...

There's a way around going bare-handed, one that still gives you all the phone-ready access you need for any winter pursuit: The best touchscreen gloves are here to save the day (figuratively ...

There are currently shortages of the Fiasp FlexTouch insulin pen which could affect people living with diabetes who take Fiasp insulin. Here’s what you need to know.

A great pair of touchscreen gloves can help you easily manipulate your smartphone or e-reader while keeping your hands warm while outdoors this winter. Touchscreen gloves are different from other ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...